Form 8-K - Current report:
SEC Accession No. 0001157523-23-000020
Filing Date
2023-01-05
Accepted
2023-01-05 16:16:53
Documents
13
Period of Report
2023-01-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 USANA HEALTH SCIENCES, INC. 8-K a53173940.htm   iXBRL 8-K 27768
2 EXHIBIT 99.1 a53173940ex99_1.htm EX-99.1 14264
  Complete submission text file 0001157523-23-000020.txt   183293

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA usna-20230105.xsd EX-101.SCH 3914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE usna-20230105_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE usna-20230105_pre.xml EX-101.PRE 16036
7 EXTRACTED XBRL INSTANCE DOCUMENT a53173940_htm.xml XML 4080
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

EIN.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35024 | Film No.: 23511521
SIC: 2833 Medicinal Chemicals & Botanical Products